These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2549156)

  • 1. Growth hormone (GH) release after administration of GH-releasing hormone in relation to endogenous 24-h GH secretion in short children.
    Gelander L; Albertsson-Wikland K
    J Endocrinol; 1989 Jul; 122(1):61-8. PubMed ID: 2549156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of 24-hour growth hormone secretion after continuous subcutaneous infusion of growth hormone-releasing hormone (GHRH (1-29)NH2) in short children with low 24-hour growth hormone secretion.
    Tauber MT; Pienkowski C; Landier F; Gunnarsson R; Rochiccioli P
    Acta Paediatr Scand Suppl; 1989; 349():117-22; discussion 123-4. PubMed ID: 2546370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intranasal calcitonin administration on pituitary GH response to hGHRH (1-29)NH2 in normal adult subjects.
    Giustina A; Romanelli G; Doga M; Pizzocolo G; Giustina G
    Clin Endocrinol (Oxf); 1989 Jun; 30(6):699-704. PubMed ID: 2556224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute intravenous injection of two growth hormone-releasing hormones (GHRH 1-40 and 1-29) on serum growth hormone and other pituitary hormones in short children with pulsatile growth hormone secretion.
    Gelander L; Lindstedt G; Selstam G; Wide L; Albertsson-Wikland K
    Horm Res; 1989; 31(5-6):213-20. PubMed ID: 2515143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous growth hormone-releasing hormone augments pulsatile nocturnal GH release in GH-insufficient children, but may also raise basal GH secretion.
    Ross RJ; Kirk JM; Tsagarakis S; Trainer PJ; Ciccarelli E; Touzel R; Grossman A; Savage MO; Besser GM
    Clin Endocrinol (Oxf); 1990 Aug; 33(2):239-48. PubMed ID: 2225481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct effects of corticotrophin-releasing hormone on stimulated growth hormone secretion.
    Raza J; Massoud AF; Hindmarsh PC; Robinson IC; Brook CG
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):217-22. PubMed ID: 9579235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction between clonidine and growth hormone releasing hormone in the stimulation of growth hormone secretion in man.
    Suri D; Hindmarsh PC; Brain CE; Pringle PJ; Brook CG
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):399-406. PubMed ID: 2147600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone (GH) response to GH-releasing hormone in short children: lack of correlation with endogenous nocturnal GH secretion.
    Seminara S; Filpo A; Piccinini P; La Cauza F; Cappa M; Faedda A; Loche S
    J Endocrinol Invest; 1997 Mar; 20(3):118-21. PubMed ID: 9186816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.
    Ionescu M; Frohman LA
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4792-7. PubMed ID: 17018654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation by propranolol of growth hormone-releasing hormone-(1-44)-NH2-induced growth hormone release in normal short and normal children.
    Chihara K; Kodama H; Kaji H; Kita T; Kashio Y; Okimura Y; Abe H; Fujita T
    J Clin Endocrinol Metab; 1985 Aug; 61(2):229-33. PubMed ID: 2989315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals.
    Achermann JC; Hindmarsh PC; Robinson IC; Matthews DR; Brook CG
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):575-85. PubMed ID: 10594518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone release.
    Blacklay A; Grossman A; Ross RJ; Savage MO; Davies PS; Plowman PN; Coy DH; Besser GM
    J Endocrinol; 1986 Jan; 108(1):25-9. PubMed ID: 2868066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone responses to growth hormone-releasing hormone (1-29)-NH2 and a D-Ala2 analog in normal men.
    Barron JL; Coy DH; Millar RP
    Peptides; 1985; 6(3):575-7. PubMed ID: 2866496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained improvement in growth velocity and recovery from suboptimal growth hormone (GH) secretion after treatment with human pituitary GH-releasing hormone-(1-44)-NH2.
    Lifshitz F; Lanes R; Pugliese M; Fort P; Perez I; Puentes S; Cervantes C; Gunczler P; Chasalow FI; Recker B
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1255-60. PubMed ID: 1430086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of continuous subcutaneous growth hormone-releasing hormone (GHRH (1-29)NH2) infusions to augment growth hormone secretion and to promote growth.
    Brain C; Hindmarsh PC; Pringle PJ; Brook CG
    Acta Paediatr Scand Suppl; 1989; 349():109-13; discussion 123-4. PubMed ID: 2546369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
    Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age and sex on basal secretion of growth hormone (GH) and on GH-induced release by porcine GH-releasing factor pGRF(1-29NH2) in growing pigs.
    Dubreuil P; Pelletier G; Petitclerc D; Lapierre H; Couture Y; Brazeau P; Gaudreau P; Morisset J
    Domest Anim Endocrinol; 1987 Oct; 4(4):299-307. PubMed ID: 2907313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses to analogues of growth hormone-releasing hormone in normal subjects, and in growth-hormone deficient children and young adults.
    Grossman A; Savage MO; Lytras N; Preece MA; Sueiras-Diaz J; Coy DH; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):321-30. PubMed ID: 6236914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.